| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.29 | 0.1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |